Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 22, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

[Retroperitoneal lymphadenectomy - pro robotic].

P Albers1

  • 1Klinik für Urologie, Universitätsklinikum, Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Deutschland. urologie@uni-duesseldorf.de

Der Urologe. Ausg. A
|April 27, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission.

Magnetic resonance imaging·2025
Same author

MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer.

European radiology·2024
Same author

MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer.

European journal of radiology·2024
Same author

Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI.

Clinical radiology·2024
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Primary retroperitoneal lymph node dissection (RPLND) indications are evolving for clinical stage I non-seminomatous germ cell tumors. Minimally invasive techniques, especially robotic-assisted RPLND, show promise but require careful patient selection and surgeon expertise.

Area of Science:

  • Urology
  • Surgical Oncology
  • Oncology

Context:

  • Indications for primary retroperitoneal lymph node dissection (RPLND) in clinical stage I non-seminomatous germ cell tumors have shifted.
  • Initial surgical staging is now reserved for exceptional cases like pure teratoma.

Purpose:

  • To evaluate the oncological and therapeutic effects of minimally invasive versus open surgery for RPLND in high-risk patients.
  • To assess the feasibility and outcomes of laparoscopic and robotic-assisted RPLND, particularly post-chemotherapy.

Summary:

  • Sparse data exist on minimally invasive approaches compared to open surgery for staging and treating high-risk patients.
  • Laparoscopic post-chemotherapy RPLND is feasible but requires highly selected patients.
  • Robotic-assisted RPLND offers potential safety and oncological advantages over laparoscopic methods, especially for managing vascular structures in post-chemotherapy cases.

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Related Experiment Videos

Last Updated: May 22, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Impact:

  • Robotic-assisted RPLND may improve safety and oncological outcomes, particularly in complex post-chemotherapy dissections.
  • Careful patient selection is crucial for robotic-assisted RPLND, focusing on smaller residual tumors and avoiding major vessel involvement.
  • Surgeons must possess advanced endoscopic skills for major vessel lesion management in robotic-assisted RPLND.